| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |